Scopus
🔓 Açık Erişim YÖKSİS Eşleşti
Aripiprozole-induced diplopia:A case report
Klinik Psikofarmakoloji Bulteni · Aralık 2013
YÖKSİS Kayıtları
Aripiprozole induced diplopia a case report
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY · 2013 SCI-Expanded
PROFESÖR YAVUZ SELVİ →
Makale Bilgileri
DergiKlinik Psikofarmakoloji Bulteni
Yayın TarihiAralık 2013
Cilt / Sayfa23 · 353-356
Scopus ID2-s2.0-84891790798
Erişim🔓 Açık Erişim
Özet
Diplopia is a condition that involves seeing double and impairs quality of life. Acute diplopia can be seen with some general medical drugs and psychotropic drugs. Aripiprazole is a new atypical antipsychotic agent; it has partial agonist activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors. This paper reports development of diplopia, a rare adverse effect of psychotropic drugs, in a 24 year old patient with schizophreniform disorder following use of oral aripiprazole. Clinicians should keep in mind that diplopia may occur with aripiprazole treatment.
Yazarlar (4)
1
Abdullah Atli
2
Yavuz Selvi
3
Aydin Yildiz
4
Mehmet Cemal Kaya
Anahtar Kelimeler
Adverse effect
Aripiprazole
Diplopia
Kurumlar
Balikligol State Hospital
Sanliurfa Turkey
Dicle University, Faculty of Medicine
Diyarbakir Turkey
Selçuk Üniversitesi
Selçuklu Turkey
Metrikler
3
Atıf
4
Yazar
3
Anahtar Kelime